Small protein plays a big role in viral battles
Extracellular vesicles, or EVs, play an important role in communication among cells. Almost all cells can release EVs, which carry content that varies according to the cell type. In response to viruses, immune cells will release EVs containing information that can help the body fight viral replication and infection. But what happens when a complex pathogen hijacks this system?
Luis daSilva’s research group at the University of São Paulo in Ribeirão Preto studies the endomembrane system of cells with particular interest in the molecular mechanisms of human immunodeficiency virus, or HIV. Viruses can take advantage of this system and impair the immune system’s ability to prevent infection. Researchers have thoroughly studied and characterized HIV’s specific proteins, and they recognize HIV accessory proteins as important virulence factors for HIV-1 pathogenesis.
In in Â鶹´«Ã½É«ÇéƬ and Cellular Proteomics, the daSilva group writes about their work studying the HIV accessory protein negative regulatory factor, or Nef, in the context of EVs. Nef allows easier viral replication and spread in host cells, and it also modifies the host’s EVs. The authors investigated the impact of this manipulation by Nef through a proteomic analysis of EVs derived from lymphocytes known as T cells.
Mara Elisama da Silva Januário is the first author of the paper. “Our study unveils the influence of Nef on the protein content of EVs released from T lymphocytes, cells that play a major role in the body’s defense,” she said. “Our recent findings highlight Nef as a global modulator of EV proteome.”
Specifically, Nef downregulates proteins in EVs that are important in the body’s antiviral response to HIV-1, including interferon-induced transmembrane proteins, or IFITMs. When IFITMs are reduced in EVs, key antiviral activities are mitigated. These proteins are among several whose expression is disrupted by Nef in HIV-1 infection.
The researchers found that Nef could modify the levels of more than 35% of the proteins identified in EVs, and among the decreased proteins were three members of the IFITM family. These proteins are pivotal in the body’s antiviral response against viruses including Zika, dengue, influenza and HIV.
“By decoding these intricate cellular dialogues, our work contributes a small but significant piece to the broader narrative of scientific discovery surrounding HIV-1 infection, offering potential avenues for advancements in medical interventions,” da Silva Januário said.
Unraveling the biological significance of altered proteins in EVs in relation to viral infection and replication are important next steps, she said. “We anticipate that further exploration in this direction will provide valuable insights for the field, shedding light on the intricate processes influenced by Nef and contributing to a deeper understanding of the broader implications for viral dynamics.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Elucidating how chemotherapy induces neurotoxicity
Andre Nussenzweig will receive the Bert and Natalie Vallee Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Where do we search for the fundamental stuff of life?
Recent books by Thomas Cech and Sara Imari Walker offer two perspectives on where to look for the basic properties that define living things.
UCLA researchers engineer experimental drug for preventing heart failure after heart attacks
This new single-dose therapy blocks a protein that increases inflammation and shows promise in enhancing muscle repair in preclinical models.
The decision to eat may come down to these three neurons
The circuit that connects a hunger-signaling hormone to the jaw to stimulate chewing movements is surprisingly simple, Rockefeller University researchers have found.
Curiosity turned a dietitian into a lipid scientist
Judy Storch will receive the Avanti Award in Lipids at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
From receptor research to cancer drug development: The impact of RTKs
Joseph Schlessinger will receive the ASBMB Herbert Tabor Research Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.